AVAI BIO, INC. Excess Tax Benefit from Share-based Compensation, Financing Activities
AVAI BIO, INC. (AVAI) reported Excess Tax Benefit from Share-based Compensation, Financing Activities of $2.50 thousand for the 12-month period ending 2020-03-31, per its 10-K filed 2020-08-13.
Discontinued › Notes
us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities · last filed 2020-08-13
- AVAI BIO, INC. excess tax benefit from share-based compensation, financing activities for fiscal 2020 was $2.50K.
- AVAI BIO, INC. excess tax benefit from share-based compensation, financing activities for fiscal 2019 was -$16.43K.
| Period end | Excess Tax Benefit from Share-based Compensation, Financing Activities 4 month | Excess Tax Benefit from Share-based Compensation, Financing Activities 12 month |
|---|---|---|
| 2020-03-31 | $2.50K 10-K · filed 2020-08-13 | |
| 2019-03-31 | -$16.43K 10-K · filed 2019-07-15 | |
| 2018-03-31 | -$155.00 10-K · filed 2019-07-15 |